Table 3.
Multivariate analyses of prognostic factors for overall survival in MDS patients
| OS multivariate analysis | |||
|---|---|---|---|
| HRa | 95% CI | p value | |
| Sex | 0.385 | 0.189–0.786 | .009 |
| IPSS stratification | 1.525 | 1.076–2.161 | .018 |
| MIR‐378 hypomethylation | 1.709 | 0.830–3.519 | .146 |
| IDH1/2 mutation | 7.827 | 0.685–89.402 | .098 |
| DNMT3A mutation | 2.530 | 0.758–8.443 | .131 |
| U2AF1 mutation | 1.410 | 0.364–5.456 | .619 |
| SF3B1 mutation | 3.240 | 0.898–11.693 | .073 |
Abbreviations: CI, confidential interval; HR, hazard ratio; IPSS, International Prognostic Scoring System; MDS, myelodysplastic syndrome; OS, overall survival.
a
HR >1 indicates an increased risk of an event for the first category listed.